Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Capstone Therapeutics and LipimetiX enter joint venture

Aug. 7, 2012

Mouse model of McArdle's disease created / News in Context

Aug. 7, 2012

Korean group prepares new GPR119 receptor ligands

Aug. 6, 2012

Shionogi files NDA for recombinant human leptin

Aug. 2, 2012

Depomed submits Serada NDA

Aug. 2, 2012

FDA issues complete response letter for rilonacept sBLA

July 31, 2012

Japanese team designs new MGAT2 inhibitors

July 31, 2012

Novel acetyl-CoA carboxylase inhibitors developed in India

July 31, 2012

Cadila Healthcare divulges novel LDL receptor ligands

July 31, 2012

Takeda resubmits alogliptin product NDAs

July 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...